| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-08-2610 |
| P698 | PubMed publication ID | 19147558 |
| P50 | author | Markus Tolnay | Q47157920 |
| P2093 | author name string | Robert Kiss | |
| Markus Tolnay | |||
| Ruth Chiquet-Ehrismann | |||
| Martin Degen | |||
| Adrian Merlo | |||
| Christian Zweifel | |||
| Monika E Hegi | |||
| Marie-France Hamou | |||
| Jean-Louis Boulay | |||
| Anthony Ghaffari | |||
| Susanne Mergenthaler | |||
| André R Miserez | |||
| Morten Wasner | |||
| Balasubramanian Sivasankaran | |||
| Maddalena M Lino | |||
| Mihai-Constantin S Ionescu | |||
| P2860 | cites work | Critical role of notch signaling in osteosarcoma invasion and metastasis | Q39352960 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 458-465 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas | |
| P478 | volume | 69 |
| Q36792047 | A migration signature and plasma biomarker panel for pancreatic adenocarcinoma |
| Q48709006 | Activity-dependent Notch signalling in the hypothalamic-neurohypophysial system of adult mouse brains |
| Q45831305 | Advances in Understanding of Structural Reorganization in the Hypothalamic Neurosecretory System |
| Q35214557 | Advances in tenascin-C biology |
| Q35157948 | Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility |
| Q34887528 | Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer |
| Q42222863 | Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry |
| Q33966158 | Deletion of RBP-J in adult mice leads to the onset of aortic valve degenerative diseases |
| Q34603835 | Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival |
| Q39067988 | Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells |
| Q42425945 | Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses |
| Q47713155 | Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study |
| Q36619107 | Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling. |
| Q37165859 | Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression |
| Q49719103 | Glioma infiltration and extracellular matrix: key players and modulators. |
| Q44886553 | High Jagged1 expression is associated with poor outcome in primary glioblastoma |
| Q36150889 | High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma |
| Q33835228 | Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach |
| Q34363706 | Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. |
| Q89529262 | Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy |
| Q39397148 | Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. |
| Q84356494 | Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer |
| Q41141296 | JMJD3 and NF-κB-dependent activation of Notch1 gene is required for keratinocyte migration during skin wound healing |
| Q33588294 | Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells |
| Q36663581 | Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis |
| Q39168771 | MicroRNA-107 inhibits U87 glioma stem cells growth and invasion |
| Q39214165 | MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression |
| Q60921650 | N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling |
| Q33883897 | NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts |
| Q34992547 | Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas |
| Q37297583 | Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma |
| Q37785199 | Notch Targets and Their Regulation |
| Q35170287 | Notch signaling activation in pediatric low-grade astrocytoma |
| Q33747041 | Notch signaling in glioblastoma: a developmental drug target? |
| Q34982347 | Notch signaling proteins: legitimate targets for cancer therapy |
| Q46402883 | Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress |
| Q55463490 | Notch1 is an independent prognostic factor for patients with glioma. |
| Q38324552 | Notching on Cancer's Door: Notch Signaling in Brain Tumors |
| Q35348365 | Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. |
| Q60921919 | Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma |
| Q57790000 | Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches |
| Q37503365 | Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. |
| Q35955393 | Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients |
| Q36941324 | Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade |
| Q34335672 | RBPJ is a novel target for rhabdomyosarcoma therapy |
| Q48670149 | Rai is a new regulator of neural progenitor migration and glioblastoma invasion |
| Q37640483 | Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. |
| Q64075342 | Role of Notch Signaling Pathway in Glioblastoma Pathogenesis |
| Q38361238 | Role of tenascins in the ECM of gliomas |
| Q34487956 | Short hairpin RNA targeting Notch2 inhibits U87 human glioma cell proliferation by inducing cell cycle arrest and apoptosis in vitro and in vivo |
| Q27010580 | Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide |
| Q34754083 | Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo |
| Q35577928 | Tenascin C in metastasis: A view from the invasive front |
| Q38239651 | Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system |
| Q64053923 | Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease |
| Q47434020 | Tenascin-C promotes differentiation of rat dental pulp cells in vitro |
| Q27023815 | Tenascin-C: Form versus function |
| Q33694568 | Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro |
| Q35006502 | Tenascins and the importance of adhesion modulation |
| Q64118486 | The Expression and Possible Functions of Tenascin-W During Development and Disease |
| Q35739881 | The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma |
| Q92889047 | The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target |
| Q39280466 | The role of tenascin-C in tissue injury and tumorigenesis |
| Q92382849 | Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme |
| Q26849961 | Transcriptional regulation of tenascin genes |
Search more.